← Leaderboards
Daniel Gonzalez
Univ Of North Carolina Chapel Hill
$6,378,664
Attributed
$9,743,327
Total exposure
7
Grants
5
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2.5M · FY2015–25$2.5M$1.9M$1.3M$625K$0
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$9,743,327 · 7
By mechanism
R01$6,008,059 · 3
T32$2,129,985 · 2
K12$878,533 · 1
K23$726,750 · 1
Top collaborators
- Kim L Brouwer6 shared
- Daniel K Benjamin4 shared
- Bridgette L. Jones4 shared
- Adriana H Tremoulet4 shared
- Jason E. Lang3 shared
- Matthew Laughon3 shared
- Paul B Watkins3 shared
Most similar at Univ Of North Carolina Chapel Hill
Same institution · by research overlap
- Mary F Paine$16,138,249
- Ian J Davis$7,130,869
- Daniel Walker Belsky$6,855,166
- Beverly H Koller$30,354,187
- Victor Mwapasa$1,918,997
Others in their field
Top investigators on “Childhood”
- Gregory H Reaman · National Childhood Cancer Foundation$268,060,146
- Barbara Driver · Westat, Inc.$206,410,885
- Sharon A Nachman · Johns Hopkins University$191,166,598
- Peter C Adamson · National Childhood Cancer Foundation$190,988,407
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$187,267,729
- James E. Gern · University Of Wisconsin-Madison$149,875,125
Research focus
ChildhoodClinical PharmacologyTrainingNational Institute Of Child Health And Human DevelopmentPharmaceutical PreparationsEnvironmentClinical TrialsRecording Of Previous EventsDrug KineticsDoseSkillsResearch PersonnelPublic HealthAdultPhysiologicalAffectProspectiveEvaluationChildDoctor Of PharmacyInfantDoctor Of PhilosophyBaseTraining Programs
Grant awards (27)
UNC-Duke Collaborative Clinical Pharmacology Postdoctoral Training Program$799,378
T32 · FY2025 · GM
PRISM$654,096
R01 · FY2025 · HD
National Career Development Program for Researchers in Pediatric Clinical Pharmacology$292,194
K12 · FY2025 · HD · contact PI
Duke-UNC Collaborative Pediatric Clinical Pharmacology Postdoctoral Training Program$210,040
T32 · FY2025 · HD · contact PI
PRISM$656,285
R01 · FY2024 · HD
Application of Physiologically-Based Pharmacokinetic Modeling to Characterize Drug-Drug Interactions in Infants$652,356
R01 · FY2024 · HD · contact PI
National Career Development Program for Researchers in Pediatric Clinical Pharmacology$292,194
K12 · FY2024 · HD · contact PI
Duke-UNC Collaborative Pediatric Clinical Pharmacology Postdoctoral Training Program$191,111
T32 · FY2024 · HD · contact PI
UNC-Duke Collaborative Clinical Pharmacology Postdoctoral Training Program$1
T32 · FY2024 · GM
PRISM$764,847
R01 · FY2023 · HD
UNC-Duke Collaborative Clinical Pharmacology Postdoctoral Training Program$744,336
T32 · FY2023 · GM
Application of Physiologically-Based Pharmacokinetic Modeling to Characterize Drug-Drug Interactions in Infants$429,327
R01 · FY2023 · HD · contact PI
National Career Development Program for Researchers in Pediatric Clinical Pharmacology$294,144
K12 · FY2023 · HD · contact PI
Duke-UNC Collaborative Pediatric Clinical Pharmacology Postdoctoral Training Program$185,119
T32 · FY2023 · HD · contact PI
Application of Physiologically-Based Pharmacokinetic Modeling to Characterize Drug-Drug Interactions in Infants$71,519
R01 · FY2023 · HD · contact PI
National Career Development Program for Researchers in Pediatric Clinical Pharmacology$1
K12 · FY2023 · HD · contact PI
Application of Physiologically-Based Pharmacokinetic Modeling to Characterize Drug-Drug Interactions in Infants$491,626
R01 · FY2022 · HD · contact PI
Physiologically-Based Pharmacokinetic Modeling to Guide Drug Dosing in Children with Obesity$509,276
R01 · FY2021 · HD · contact PI
Application of Physiologically-Based Pharmacokinetic Modeling to Characterize Drug-Drug Interactions in Infants$485,791
R01 · FY2021 · HD · contact PI
Physiologically-Based Pharmacokinetic Modeling to Guide Drug Dosing in Children with Obesity$514,533
R01 · FY2020 · HD · contact PI
Physiologically-Based Pharmacokinetic Modeling to Guide Drug Dosing in Children with Obesity$512,014
R01 · FY2019 · HD · contact PI
Use of Physiologically-Based PK/PD Models to Streamline Drug Approvals$155,425
K23 · FY2019 · HD · contact PI
Physiologically-Based Pharmacokinetic Modeling to Guide Drug Dosing in Children with Obesity$266,389
R01 · FY2018 · HD · contact PI
Use of Physiologically-Based PK/PD Models to Streamline Drug Approvals$155,425
K23 · FY2018 · HD · contact PI
Use of Physiologically-Based PK/PD Models to Streamline Drug Approvals$155,425
K23 · FY2017 · HD · contact PI
Use of Physiologically-Based PK/PD Models to Streamline Drug Approvals$130,305
K23 · FY2016 · HD · contact PI
Use of Physiologically-Based PK/PD Models to Streamline Drug Approvals$130,170
K23 · FY2015 · HD · contact PI